Tear Dynamics After Restasis Treatment in Dry Eye Patients
- Conditions
- Dry Eye
- Registration Number
- NCT00706940
- Lead Sponsor
- University of Miami
- Brief Summary
Observe the changes of tear volume in dry eye patients after Restasis treatment of 3 months and during 6-month follow-up after discontinuation of study treatment.
- Detailed Description
Using an imaging device name optical coherence tomography to image the tear volume in dry eye patients before and after Restasis treatment.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 60
The participant will be eligible for entry in the study if s/he:
- Is at least 18 years old and has full legal capacity to volunteer;
- Has read and signed the IRB Informed Consent Document;
- Is willing and able to follow participant instructions;
- Has clear corneas;
- Has 20/100 uncorrected visual acuity or better;
- Has dry eye according to the study definition of DES (study subjects);
- Has not use Restasis within 3 months.
The subjects will ineligible for entry into the study if s/he:
- Has any systemic disease affecting ocular health except for Sjögren's syndrome;
- Is using any systemic or topical medications that will affect ocular health except for artificial tears;
- Has an active ocular disease other than DES, or Sjögren's syndrome
- Has any clinically significant lid or conjunctival abnormalities, neovascularization, corneal scars or corneal opacities;
- Has limbal or bulbar injection or corneal staining that was clinically significant, which are not due to DES;
- Has worn rigid gas permeable lenses within 1 year and during the study;
- Has had surgery or an eye injury within 6 months;
- Was a soft contact lens wearer within 2 weeks and during the study.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Tear meniscus volume after treatment 3 months Significant increase in tear meniscus volume was found in patients after 3 months of treatment.
Increase in tear volume after the 3-month treatment and returned to baseline during 6-month follow-up after discontinuation of study treatment. 3 months for treatment and follow-up of 6 months after discontinuation of study treatment.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Bascom Palmer Eye Institute
🇺🇸Miami, Florida, United States